HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Smart agriculture provides solutions for BRI countries
- Foreign experts, journalists explore China's cultural heritage
- Jiangxi county pioneers innovative rural development approach
- China's 'medicine capital' company goes fully automated
- Beijing prosecutors helping errant minors to get back on track
- Copyright Society of China wins approval to be observer of world intellectual property body